Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × Capsaicin × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuralgia 1 Head and Neck Neoplasms 1 Breast Neoplasms 1 Agnosia 1

Interventions

Cisplatin 113 Radiotherapy 71 Cetuximab 68 Docetaxel 50 Paclitaxel 41 pembrolizumab 39 Carboplatin 39 Fluorouracil 38 Radiotherapy, Intensity-Modulated 30 Drug Therapy 15 Radiation 13 Gefitinib 13 Nivolumab 11 Gemcitabine 11 Surgical Procedures, Operative 10 Bevacizumab 10 Amifostine 9 tislelizumab 8 Pemetrexed 8 Oxaliplatin 8 Erlotinib Hydrochloride 8 Celecoxib 8 Capecitabine 8 durvalumab 7 atezolizumab 7 Filgrastim 7 Panitumumab 6 Albumin-Bound Paclitaxel 6 130-nm albumin-bound paclitaxel 6 toripalimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04704453 2025-07-31

TEC-ORL

Institut Claudius Regaud

Phase 2 Completed

Head and Neck Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡